February 1, 2024 FamilieSCN2A Partners with C-Path’s RDCA-DAP, Advancing Research Efforts for SCN2A-Related Disorders n a significant step to enhance research efforts for SCN2A-related autism and epilepsy, Critical Path Institute (C-Path) and Famil
January 30, 2024 Webinar Recording: TRxA 2024 Funding Opportunities TRxA’s focus is translating early-stage novel therapeutics into Investigational New Drug (IND) supporting data packages that...
January 25, 2024 C-Path Promotes Cécile Ollivier to Vice President of Global Affairs, Expanding Leadership in Drug Development Critical Path Institute (C-Path) today announced the promotion of Cécile Ollivier, M.S., from Managing Director, Europe to...
C-Path, CPP Share Manuscript That Redefines Parkinson’s Disease C-Path and its Critical Path for Parkinson’s Consortium are pleased to share a new manuscript that redefines Parkinson’s...
January 22, 2024 C-Path’s TRxA Announces its 2024 Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced...
April 17, 2024-April 18, 2024 2024 Clinical Outcome Assessment Program Annual Meeting On April 17-18, 2024, the 2024 Clinical Outcome Assessment Annual Meeting...
January 11, 2024 C-Path to Lead New Task Force Aimed at Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases Critical Path Institute (C-Path) today announced the launch of a task force focused on accelerating drug...
February 8, 2024 TRxA 2024 Funding Opportunities Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is proud to announce its 2024 global...
January 9, 2024 Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes This webinar presents an overview of the published article in the Journal of the Society for Clinical Data Management that...
January 9, 2024 C-Path Appoints Dr. Klaus Romero as New CEO Longtime quantitative medicine and regulatory science expert to spearhead C-Path's collaborative efforts in accelerating...